The News Review:

- Top Academic Medical Centers Research Institutions Partners …
- Immunotherapy Effective Against Neuroblastoma In Children
- PRA International Participating in Pharmacoeconomics and utcomes …
- » Senior Clinical Research Associate (Home-Based)
- Navigating patient recruitment on global stage
- SAR Conference and Call for Abstracts
- Cancer experts aim to double number in clinical trials

Top Academic Medical Centers Research Institutions Partners …
PR Newswire (press release)
gathered to discuss a variety of initiatives and to hear speakers from University of California at San Francisco University of Kansas Medical Center and the University of Miami Miller School of Medicine. Speakers also included leaders from the Comprehensive Cancer Centers at University of Chicago Columbia University and University of Texas MD Anderson as well as the National Cancer Center of South Korea. Presenters shared their achievements using the Velos flagship product Velos eResearch to bring quality and efficiency to their clinical research programs. They addressed other topics such as strategies to facilitate better data standards for medical research. This year’s meeting was highlighted by customer enthusiasm for sharing experiences and accomplishments. Attendees were eager to collaborate in adopting state-of-the-art clinical research system infrastructure. The Velos eResearch system allows customers to internally and collaboratively manage thousands of clinical trials.
Related from Fathernickthomas: Third-hand smoke: Another reason to quit smoking

Immunotherapy Effective Against Neuroblastoma In Children
Science Daily (press release)
"This is the first time in many years that we have been able to improve the ‘cure rate’ for neuroblastoma patients" she said. "This new therapy can help us improve care and perhaps offer new hope to many patients and families. "Yu and her team conducted the early phase I and phase II trials at the General Clinical Research Center at UC San Diego Medical Center. ther co-authors include Andrew Gilman Carolinas Medical Centre; M. Fevzi zkaynak New York Medical College; Susan Cohn University of Chicago; John Maris Children’s Hospital of Philadelphia; Paul Sondel University of Wisconsin; W. London University of Florida; S.

PRA International Participating in Pharmacoeconomics and utcomes …
PR Newswire (press release)
About PRA InternationalPRA International is a global Clinical Research rganization providing services through all phases of clinical development. PRA has supported over 2100 clinical trials through its 35 global offices. PRA’s therapeutic expertise global reach and project experience combined with extensive local knowledge and our differentiating PERSNAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy – THE PERSNAL ELEMENT – recognizes that true client service comes only from trained empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.

» Senior Clinical Research Associate (Home-Based)
Hays Pharma
Apply now!Are you looking for more flexibility in your current work situation? Are you looking for a step up in your personal career? r are you looking for a challenge to strengthen your success in clinical research? Now here is your chance!Job SummaryMy client a global leading organisation within the pharmaceutical industry is presently seeking an experienced Clinical Research Associate to strengthen their clinical team in The Netherlands. n behalf of my client you will be responsible to initiate monitor and manage top level clinical projects in The Netherlands. For more information please contact Daniel on 0044 (0) 207 922 7158. Home-based Senior Clinical Research AssociateJob Description- Significant number of years of clinical research monitoring experience (including pre-study initiation routine monitoring and closeout visits).

Navigating patient recruitment on global stage
R&D Directions (subscription)
Countries like India China and Russia dubbed by many as emerging superpowers of clinical research offer several advantages for pharmaceutical sponsors most notably access to large pools of treatment-naïve patients with both first and third-world diseases. While significant regulatory ethical and cultural challenges exist in these locations as well the expansion of medical research into regions such as Asia Pacific Eastern Europe and South America is clearly evident. As the clinical research landscape continues to widen so do the business challenges for contract research organizations and patient recruitment providers. These companies now more than ever must be capable of developing and managing recruitment programs on a global scale with strategies that meet each local site’s needs in whatever country they are located. According to Donna Beasley VP of operation for Praxis a patient recruitment provider expanding the geographic boundaries of coordinated study enrollment adds several variables to consider into the mix.

SAR Conference and Call for Abstracts
Acupuncture Today
Leading researchers will give keynote and panel presentations assessing recent progress challenges and opportunities for future research. Members of the national and international acupuncture research communities will also present original data Pre-conference workshops will focus on fundamentals of riental medicine research for practitioners students and educators new to the field. Abstracts are solicited for the areas of clinical research basic science and research methodology pertaining to acupuncture as well as other components of M including traditional herbs tai chi and qi gong. Please upload abstracts to.

Cancer experts aim to double number in clinical trials
The Gazette (Montreal)
Doctors are hopeful a $1. 25-million grant from Pfizer Canada announced yesterday could help change that. Pfizer’s grant will be funnelled into a province-wide reorganization of cancer care called Quebec-Clinical Research rganization in Cancer (Q-CRC) whose mission is to set up the infrastructure that will eventually link researchers from the four university medical schools and research centres with cancer patients. The goal is to optimize patient care by combining scientific and clinical expertise Batist said. The head office connecting various medical centres to the regions will be set up at the Segal Cancer Centre. The money will also be used to cover the costs of data managers archivists and software and to recruit nurses who will identify patients eligible for certain studies said Luc Bélanger director of the Laval University Cancer Research Centre in Quebec. nce the pilot project gets off the ground the consortium will be seeking provincial government funds for the next stage.